company background image
DBT logo

Ben Tre Pharmaceutical HOSE:DBT Stock Report

Last Price

₫13.50k

Market Cap

₫219.6b

7D

-3.6%

1Y

0.7%

Updated

21 Jun, 2024

Data

Company Financials

Ben Tre Pharmaceutical Joint Stock Company

HOSE:DBT Stock Report

Market Cap: ₫219.6b

DBT Stock Overview

Manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally.

DBT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Ben Tre Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ben Tre Pharmaceutical
Historical stock prices
Current Share Price₫13,500.00
52 Week High₫14,700.00
52 Week Low₫11,100.00
Beta0
11 Month Change7.14%
3 Month Change8.87%
1 Year Change0.75%
33 Year Change1.71%
5 Year Change28.86%
Change since IPO9.58%

Recent News & Updates

Recent updates

Shareholder Returns

DBTVN PharmaceuticalsVN Market
7D-3.6%1.2%-1.7%
1Y0.7%9.9%12.1%

Return vs Industry: DBT underperformed the VN Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: DBT underperformed the VN Market which returned 12.1% over the past year.

Price Volatility

Is DBT's price volatile compared to industry and market?
DBT volatility
DBT Average Weekly Movement3.3%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.4%
10% least volatile stocks in VN Market2.8%

Stable Share Price: DBT has not had significant price volatility in the past 3 months.

Volatility Over Time: DBT's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1963n/an/awww.bepharco.com

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines.

Ben Tre Pharmaceutical Joint Stock Company Fundamentals Summary

How do Ben Tre Pharmaceutical's earnings and revenue compare to its market cap?
DBT fundamental statistics
Market cap₫219.58b
Earnings (TTM)₫16.89b
Revenue (TTM)₫828.64b

0.0x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DBT income statement (TTM)
Revenue₫828.64b
Cost of Revenue₫628.83b
Gross Profit₫199.81b
Other Expenses₫182.92b
Earnings₫16.89b

Last Reported Earnings

Jun 30, 2020

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did DBT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.